BioCSL and PharmaJet have a new solution for uptake-hampering needlephobia. On Tuesday, the FDA approved the latter's Stratis Needle-Free Jet Injector for the delivery of bioCSL's seasonal flu vaccine, Afluria. The PharmaJet injector delivers the vaccine by means of a narrow, precise fluid stream that penetrates the skin in about one-tenth of a second, the companies said. Release